Researchers in Sweden have unveiled a major scientific advance that could reshape the future of treatment for type 1 diabetes, after successfully developing a more precise method to generate insulin-producing cells from human stem cells.
The study, conducted by teams at the Karolinska Institute and the KTH Royal Institute of Technology, demonstrated that the newly engineered cells performed with high efficiency in laboratory settings and were capable of reversing diabetes in experimental mice.
Type 1 diabetes is a chronic condition…